Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer
Clinical trial NCT04638725 · RECRUITING
Trial details
- NCT number
- NCT04638725
- Sponsor
- Centre Paul Strauss
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-15
- Primary completion
- 2033-12-15
- Enrollment
- 9000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.